LIF (leukaemia inhibitory factor) is a key cytokine for maintaining self-renewal and pluripotency of mESCs (mouse embryonic stem cells). Upon binding to the LIF receptor, LIF activates three major intracellular signalling pathways: the JAK (Janus kinase)/STAT3 (signal transducer and activator of transcription 3), PI3K (phosphoinositide 3-kinase)/AKT and SHP2 [SH2 (Src homology 2) domain-containing tyrosine phosphatase 2]/MAPK (mitogen-activated protein kinase) pathways. These pathways converge to orchestrate the gene expression pattern specific to mESCs. Among the many signalling events downstream of the LIF receptor, activation and DNA binding of the transcription factor STAT3 plays a central role in transducing LIF's functions. The fundamental role of LIF for pluripotency was highlighted further by the discovery that LIF accelerates the conversion of epiblast-derived stem cells into a more fully pluripotent state. In the present review, we provide an overview of the three major LIF signalling pathways, the molecules that interact with STAT3 and the current interpretations of the roles of LIF in pluripotency.
Skip Nav Destination
Review Article| July 27 2011
Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor
Nobuaki Kikyo 1
1Stem Cell Institute, Division of Haematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, U.S.A.
1To whom correspondence should be addressed (email firstname.lastname@example.org).
Search for other works by this author on:
- Views Icon Views
- Share Icon Share
Hiroyuki Hirai, Peter Karian, Nobuaki Kikyo; Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J 15 August 2011; 438 (1): 11–23. doi: https://doi.org/10.1042/BJ20102152
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article